This interview focuses on the Ross procedure and fresh decellularized aortic homografts as aortic valve replacement (AVR) options for pediatric patients. At the 40th European Association for Cardio-Thoracic Surgery (EACTS) Annual Meeting, Sameh Said, Chief of the Division of Pediatric and Adult Congenital Cardiac Surgery at Maria Fareri Children’s Hospital in Valhalla, New York, USA, spoke with Peter Murin, Head of the Department of Congenital Heart Defects and Pediatric Cardiac Surgery at the Medical University of Vienna, Austria.
They discussed the limited availability of smaller homograft sizes, the indications for homograft use, and the types of patients who may benefit. They also considered strategies for facilitating reoperation after homograft implantation. The discussion covered various Ross procedure techniques, subcoronary implantation, coronary incision, and the position of the coronary artery ostia. They reviewed a study by Dr. Murin on the Ross procedure and fresh decellularized aortic homografts, including its results, long-term outcomes, and reintervention rates.
They also examined cryopreserved homografts and how the choice of surgical technique depends on individual patient characteristics, with several examples. In addition, they discussed the minimally invasive pediatric heart surgery program at Medical University of Vienna and an upcoming symposium in Vienna.
At the 40th European Association for Cardio-Thoracic Surgery Annual Meeting, CTSNet connected with leading cardiothoracic surgeons from around the world to explore the latest advances in the field. Watch for additional interviews from the meeting.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
